JWX-A0108 improved the learning and memory function of Alzheimer’s disease model APP/PS1 mice by decreasing the expression of TNFalpha, IL-1beta, and IL-6 and also decreasing the phosphorylation of NF-kappaB [53]. This evidence concerns the gene APP and early-onset autosomal dominant Alzheimer disease.